3-Year Results of a Member and Physician Intervention to Reduce Risk Associated With Glucocorticoid-Induced Osteoporosis in a Health Plan

BACKGROUND: Accelerated bone loss is a well-known outcome of chronic treatment with glucocorticoids, making glucocorticoid-induced osteoporosis a significant cause of morbidity and a burden on health care resources. Recommendations for prevention and treatment of glucocorticoid-induced osteoporosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitre, Mona M., Hayes, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437640/
https://www.ncbi.nlm.nih.gov/pubmed/18439050
http://dx.doi.org/10.18553/jmcp.2008.14.3.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437640/
https://www.ncbi.nlm.nih.gov/pubmed/18439050
http://dx.doi.org/10.18553/jmcp.2008.14.3.281

Ejemplares similares